#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hyperinsulinism Non-Hodgkin's lymphoma unspecified histology indolent Immune-mediated myositis Nodal marginal zone B-cell lymphoma Urethral valves Biliary neoplasm Oesophageal atresia Vitamin B12 deficiency Cortical dysplasia Craniopharyngioma Congenital aplastic anaemia Fibrous dysplasia of bone Oesophageal adenocarcinoma stage II Noonan syndrome Partial lipodystrophy More trials…

    Learn about Rare Diseases

    Chondrosarcoma – Treatment Alveolar rhabdomyosarcoma – Treatment Erdheim-Chester disease – Diagnostics Niemann-Pick disease – Treatment Short-bowel syndrome – Trials in Disease Toxic epidermal necrolysis – Treatment Metachromatic leukodystrophy – Life with Disease Bronchiolitis obliterans syndrome – Diagnostics Rhabdomyosarcoma recurrent – Trials in Disease Angiosarcoma non-metastatic More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Cromoglicate Asp1570 Bendamustine Satoreotide Tetraxetan Glimepiride Sphingomyelin (Egg) Xenon Isosorbide Dinitrate Povetacicept ANUMIGILIMAB Img-007 Epinephrine Bitartrate Eptacog Beta (Activated) Enomimeran TRIMIPRAMINE MALEATE SODIUM TETRACHLOROPALLADATE Osilodrostat TUB-030 Heparin Sodium Nvl-655 More therapies…

    Learn about Your Condition

    Graves' disease Behcet's syndrome Ophthalmoplegia Heart transplant Binge eating Myelodysplastic syndrome Endocarditis bacterial Vascular dementia Prostate cancer metastatic Endometrial adenocarcinoma Gingival bleeding Primary hyperthyroidism Sarcoma Meningioma malignant Leukaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Cyclophosphamide and Etoposide with Radiation for High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Patients Preparing for Transplant

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Cyclophosphamide
    • Etoposide
    • Mycophenolate Mofetil
    Spain

  • Study on Long-term Safety of JNJ-81201887 for Patients with Geographic Atrophy Due to Age-related Macular Degeneration

    Recruiting

    2 1 1
    Investigated Diseases:
    • Dry age-related macular degeneration
    Investigated Drugs:
    • Adeno-Associated Virus Serotype 2 Encoding Soluble Cd59
    • Triamcinolone Acetonide
    • Prednisone
    Belgium Czechia Denmark Germany Hungary Italy +5

  • Study on the Effectiveness of Cemiplimab and Drug Combination for Patients with Oligometastatic Non-Small Cell Lung Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Tremelimumab
    • Cemiplimab
    • Ipilimumab
    France

  • Study on the Effect and Safety of Autologous Mesoangioblasts for Patients with Mitochondrial Myopathy Due to m.3243A>G Mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Mitochondrial myopathy
    Investigated Drugs:
    • Autologous Muscle Precursor Cells
    The Netherlands

  • Title: Study of ultrasound-assisted carboplatin therapy with SonoVue for children with recurrent malignant brain tumors using blood-brain barrier disruption

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Investigated Drugs:
    • Sulfur Hexafluoride
    • Carboplatin
    France

  • Study on Zanidatamab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer After Trastuzumab Deruxtecan Treatment

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Breast cancer
    Investigated Drugs:
    • Eribulin Mesylate
    • Vinorelbine
    • Zanidatamab
    Austria Belgium France Germany Greece Italy +2
Previous Page
1 … 424 425 426 427 428 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!